Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Matthew 7:25 Inc dba Thrive Pharmacy
WARNING LETTER
•Matthew 7:25 Inc dba Thrive Pharmacy•December 20, 2019

Matthew 7:25 Inc dba Thrive Pharmacy – FDA Warning Letter, Dec 20, 2019

Record Details

The FDA issued a Warning Letter to Matthew 7:25, Inc. dba Thrive Pharmacy, following an inspection from December 12-20, 2019. The inspection revealed that drug products produced by the firm failed to meet Section 503A of the FDCA conditions for exemption from certain provisions, and noted deficiencies in drug production practices.

Violations included compounding drug products, such as phentermine 37.5 mg capsules, without valid prescriptions for individually-identified patients, making them ineligible for 503A exemptions. These "ineligible drug products" were deemed adulterated under Section 501(a)(2)(B) due to significant CGMP violations. Specific CGMP failures included: lack of laboratory determination of conformance to final specifications (21 CFR 211.165(a)), inadequate stability testing programs (21 CFR 211.166(a)), and insufficient written procedures for production and process control (21 CFR 211.100(a)).

FDA analysis of Buprexone Banana Cream 6-0.6 mg Troche, Buprenorphine Watermelon 8 mg Troche, and Buprenorphine Black Cherry 2 mg Troche samples found them subpotent, containing 85.7% (80.2% for Naloxone), 92.5%, and 89

Company
Matthew 7:25 Inc dba Thrive Pharmacy
Inspection date
December 20, 2019
Product type
Drugs
Office
Office of Pharmaceutical Quality Operations Division I
People
  • Monica R. Maxwell (Program Division Director)
  • Jamillah Selby (Compliance Officer)
View Company Profile

ID · 998fee22-0925-4c7e-ba9a-135092ea58c4

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 U.S.C. 353a21 U.S.C. 352(f)(1)21.U.S.C. 355(a)21 CFR 211.165(a)21 CFR 211.166(a)21 CFR 211.100(a)21 U.S.C. 351(b)21 U.S.C. 331(k)21 U.S.C. 352(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Matthew 7:25 Inc dba Thrive Pharmacy
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.